Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tissue Repair Ltd ( (AU:TRP) ) has provided an update.
Tissue Repair Limited has announced that its 2025 Annual General Meeting will be held on 24 November 2025. The company is inviting valid nominations for the position of director to be submitted by 2 October 2025. This meeting is a significant event for stakeholders as it will address key governance issues and future directions for the company, potentially impacting its strategic operations and market positioning.
More about Tissue Repair Ltd
Tissue Repair Limited (ASX: TRP) is a Phase 3 biotechnology company focused on developing advanced wound healing agents. The company is progressing its lead drug candidate TR987® for chronic wounds and commercializing TR Pro+®, a topical treatment aimed at enhancing healing and skin quality post-cosmetic or medical procedures. Its proprietary Glucoprime® API supports a growing pipeline of therapeutic solutions.
Average Trading Volume: 110,568
Technical Sentiment Signal: Buy
For a thorough assessment of TRP stock, go to TipRanks’ Stock Analysis page.